Transcriptomics-informed pharmacology identifies epigenetic and cell cycle regulators that enhance AAV production
Recombinant adeno-associated virus (rAAV) is a widely used viral vector for gene therapy. However, these vectors have limited availability due to manufacturing challenges with productivity and quality. These challenges can be addressed by better understanding the mechanisms that influence cellular r...
Saved in:
| Main Authors: | Joshua Tworig, Francis Grafton, Kaylin Fisher, Markus Hörer, Christopher A. Reid, Mohammad A. Mandegar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Molecular Therapy: Methods & Clinical Development |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050124002006 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
E2A, VA RNA I, and L4-22k adenoviral helper genes are sufficient for AAV production in HEK293 cells
by: Jiten Doshi, et al.
Published: (2024-12-01) -
Recent Advances in Designing Adeno-Associated Virus-Based Vaccines Against Viral Infections
by: Njabulo Mnyandu, et al.
Published: (2024-10-01) -
Advances in Gene Therapy for Neurologic Disorders: An Overview
by: Pallavi Chand, et al.
Published: (2025-02-01) -
Probing aspects of extracellular vesicle associated AAV allows increased vector yield and insight into its transduction and immune-evasive properties
by: Ming Cheng, et al.
Published: (2025-03-01) -
Recombinant AAV batch profiling by nanopore sequencing elucidates product-related DNA impurities and vector genome length distribution
by: Florian Dunker-Seidler, et al.
Published: (2025-03-01)